{ "items": [ "\n\n
Caillet C. and Newton PN., (2019), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 101, 433 - 434
\n \n \n \n\n \n
\n \n \nBernier MC. et al, (2018), Rapid Communications in Mass Spectrometry, 32, 1585 - 1590
\n \n \n \n\n \n
\n \n \nVickers S. et al, (2018), BMJ Global Health, 3, e000725 - e000725
\n \n \n \n\n \n
\n \n \nLuangasanatip N. et al, (2018), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 99, 344 - 345
\n \n \n \n\n \n
\n \n \nCaillet C. et al, (2017), Drug Safety, 40, 809 - 821
\n \n \n \n\n \n
\n \n \nCaillet C. et al, (2016), DRUG SAFETY, 39, 1009 - 1009
\n \n \n \n\n \n
\n \n \nNewton PN. et al, (2016), Expert Review of Anti-infective Therapy, 14, 531 - 533
\n \n \n \n\n \n
\n \n \nCaillet C. et al, (2016), FUNDAMENTAL & CLINICAL PHARMACOLOGY, 30, 10 - 10
\n \n \n \n\n \n
\n \n \nCaillet C. et al, (2015), BMC Public Health, 15
\n \n \n \n\n \n
\n \n \nCaillet C. et al, (2014), FUNDAMENTAL & CLINICAL PHARMACOLOGY, 28, 61 - 61
\n \n \n \n\n \n
\n \n \nDespas F. et al, (2014), FUNDAMENTAL & CLINICAL PHARMACOLOGY, 28, 111 - 111
\n \n \n \n\n \n
\n \n \nCaillet C. et al, (2014), FUNDAMENTAL & CLINICAL PHARMACOLOGY, 28, 102 - 102
\n \n \n \n\n \n
\n \n \nCaillet C. et al, (2013), DRUG SAFETY, 36, 847 - 848
\n \n \n \n\n \n
\n \n \nCaillet C. et al, (2012), British Journal of Clinical Pharmacology, 74, 886 - 889
\n \n \n \n\n \n
\n \n \nDurrieu G. et al, (2012), Drug Safety, 35, 845 - 854
\n \n \n \n\n \n
\n \n \nCaillet C. et al, (2012), PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 21, 428 - 428
\n \n \n \n\n \n
\n \n \nCaillet C. et al, (2012), FUNDAMENTAL & CLINICAL PHARMACOLOGY, 26, 70 - 70
\n \n \n \n\n \n
\n \n \nDurrieu G. et al, (2011), Therapies, 66, 527 - 540
\n \n \n \n\n \n
\n \n \nCaillet C. et al, (2011), European Journal of Clinical Pharmacology, 67, 649 - 651
\n \n \n \n\n \n
\n \n \nCaillet C. et al, (2011), FUNDAMENTAL & CLINICAL PHARMACOLOGY, 25, 16 - 16
\n \n \n \n\n \n
\n \n \n